On Demand Audio

Trending Antitrust Issues in Pharmaceuticals and Life Sciences

(94 reviews)

Produced on February 21, 2019

Taught by
$ 59 Health Care Law, Life Sciences, and Antitrust In Stock
Get started now

$299 / year - Access to this Course and 1,500+ Lawline courses

or

Course Information

Time 64 minutes
Difficulty Intermediate

Course Description

The pharmaceutical and life sciences market has long been a focus for antitrust enforcers, litigants, and academics. A lack of transparency into pricing, combined with a complex distribution chain, the presence of third party payers, and a nuanced regulatory scheme, have all contributed to the rise of antitrust concerns in this area. As pharmaceutical pricing continues to dominate political and legislative debates, media reports, and even everyday conversations between consumers, antitrust law is slated to play an even larger role than before in shaping the industry for the foreseeable future.

In this course, Jeff Bank, a partner in the Antitrust Group at Wilson Sonsini Goodrich & Rosati, PC, explains why antitrust is perceived by some as a solution to rising healthcare costs, reviews recent litigation and enforcement in the industry, and provides practical guidance to consider when counseling clients.


Learning Objectives:

  1. Explore why unique aspects of the pharmaceuticals and life sciences industry have led to challenging antitrust disputes
  2. Examine recent litigation and enforcement actions and forecast future trends
  3. Identify strategies for counseling clients on best business practices and litigation opportunities  

Credit Information

After completing this course, Lawline will report your attendance information to {{ accredMasterState.state.name }}. Please ensure your license number is filled out in your profile to ensure timely reporting. For more information, see our {{ accredMasterState.state.name }} CLE Requirements page . After completing this course, {{ accredMasterState.state.name }} attorneys self-report their attendance and CLE compliance. For more information on how to report your CLE courses, see our {{ accredMasterState.state.name }} CLE Requirements FAQ .

Faculty

Jeffrey Bank

Wilson Sonsini Goodrich & Rosati

Jeff Bank is a partner in Wilson Sonsini Goodrich & Rosati's New York office, where he practices antitrust litigation and counseling, particularly in the pharmaceutical industry.

As an experienced litigator representing both plaintiffs and defendants, Jeff's work has ranged from complex multi-district litigations and global cartel cases to actions against competitors. He has successfully defended pharmaceutical, technology, and media companies against class actions, and has experience in all aspects of litigation, from discovery through appeal.

Prior to joining the firm, Jeff practiced at the Federal Trade Commission's Health Care Division, where he focused on competition issues in the pharmaceutical and healthcare industry. In his current practice, he regularly counsels clients on merger clearance issues and business practices, and he has represented a diverse range of clients before the FTC, including companies from the medical device, pharmaceutical, and media sectors.

Jeff also serves as the pro bono coordinator for the New York office, and he has worked on numerous immigration and asylum-related matters. He was awarded the John Wilson Award, which is presented annually to individual attorneys who have demonstrated a significant commitment to the firm's pro bono clients. Additionally, Jeff currently serves as board president for Spoons Across America, a New York-based nonprofit.





Reviews

RB
Ronald B.

While unrelated to my practice the presentation was extremely informative.

EK
Evan K.

Riveting. Thanks!

LA
Lina A.

Excellent.

MH
Maureen H.

absolutely outstanding presentation!

MB
Matthew J. B.

The speaker was very articulate and linear -- very helpful!

MM
michele m.

Excellent content and presentation.

JS
Julie S.

Great presentation.

LS
Leonard S.

very comprehensive lecture on the subject

Load More